Saniona AB (publ) (SANION)

NASDAQ Stockholm | Biotech | Ion channel drug discovery
Free
No email, no account, no signup.
Pulling latest news for Saniona AB (publ)…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ Stockholm
Type
Biotech
Sector
Ion channel drug discovery
Market Cap
$185M
We're already tracking Saniona AB (publ) — here are the latest events we've registered

Recent News

  • On April 30, 2026, Saniona published its Annual Report for 2025. The company has also convened its Annual General Meeting for May 27, 2026, where it will discuss governance and a new incentive program. In early 2026, the company highlighted progress in its partnerships with Jazz Pharmaceuticals and Acadia Pharmaceuticals.
Want to know how this news affects Saniona AB (publ)? Order the analysis.
Order analysis – $4.99

What you get

A complete express analysis — not just a signal. Delivered as a webpage in your account.

  • Signal: BUY / HOLD / SELL — with clear reasoning
  • Sentiment score 1–10 based on news, reports, and market data
  • Risk score 1–10 (dilution, jurisdiction, execution)
  • Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
  • Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
  • Upcoming catalysts with dates
  • Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Saniona AB (publ) will be delivered in the same format.
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
Saniona AB (publ) (SANION)
Fresh analysis on demand
Order analysis – $4.99
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.